Ketonemia Clinical Trial
Official title:
Optimisation of Acute Medium Chain Triglycerides Intake Characteristics on Different Plasma Metabolites in Young and Older Participants
Compare plasma metabolites following different conditions paired with a dietary MCT beverage over an 8-hour metabolic day protocol in young and older participants.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Recruiting |
NCT04004676 -
Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise
|
N/A | |
Not yet recruiting |
NCT04576026 -
Exogenous Ketone Supplementation and Cognitive Function During Exercise
|
N/A | |
Recruiting |
NCT03895892 -
Exogenous Ketone Supplementation and Exercise Performance
|
N/A | |
Completed |
NCT03073356 -
Ketones in Heart Failure - Effects on Cardiac Efficiency
|
Phase 2 | |
Completed |
NCT04703361 -
Effects of Ketones and Niacin in Heart Failure Patients
|
Phase 2 | |
Completed |
NCT05159570 -
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)
|
N/A | |
Completed |
NCT05236335 -
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.
|
N/A | |
Recruiting |
NCT05732909 -
The Metabolic Effects of β-hydroxybutyrate on Working Skeletal Muscle
|
N/A | |
Completed |
NCT04615754 -
Ketones for Pulmonary Hypertension - Effects on Hemodynamics
|
Phase 2 | |
Completed |
NCT03959501 -
Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
|
Phase 4 | |
Completed |
NCT05980858 -
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity in Healthy Subjects
|
N/A | |
Active, not recruiting |
NCT04443426 -
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Chronic Heart Failure: Cardiovascular Effects
|
Phase 2 |